Repositorio Dspace

sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain)

Mostrar el registro sencillo del ítem

dc.contributor.author Perales, A
dc.contributor.author Delgado-Marín, Juan-Luis
dc.contributor.author de-la-Calle, M
dc.contributor.author García-Hernández, J-A
dc.contributor.author Escudero-Pastor, Ana-Isabel
dc.contributor.author Campillos, J-M
dc.contributor.author Sarabia, M-D
dc.contributor.author Laiz, B
dc.contributor.author Duque, M
dc.contributor.author Navarro, M
dc.contributor.author Calmarza, P
dc.contributor.author Hund, M
dc.contributor.author Álvarez, F-V
dc.date.accessioned 2026-02-12T12:08:28Z
dc.date.available 2026-02-12T12:08:28Z
dc.date.issued 2017-09
dc.identifier.citation Perales A, Delgado JL, De La Calle M, García-Hernández JA, Escudero AI, Campillos JM, et al. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain). Ultrasound in Obstet & Gyne. septiembre de 2017;50(3):373-82.
dc.identifier.issn 0960-7692
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/24272
dc.description.abstract OBJECTIVE: A high ratio of soluble fms-like tyrosine kinase-1 (sFlt-1) to placental growth factor (PlGF) has been linked to pre-eclampsia (PE). We evaluated the sFlt-1/PlGF ratio as a predictive marker for early-onset PE in women at risk of PE. METHODS: This prospective, Spanish, multicenter study included pregnant women with a risk factor for PE, including intrauterine growth restriction, PE, eclampsia or hemolysis, elevated liver enzymes and low platelet count syndrome in previous pregnancy, pregestational diabetes or abnormal uterine artery Doppler. The primary objective was to show that the sFlt-1/PlGF ratio at 20, 24 and 28 weeks' gestation was predictive of early-onset PE (< 34 + 0 weeks). Serum sFlt-1 and PlGF were measured at 20, 24 and 28 weeks. Multivariate logistic regression was used to develop a predictive model. RESULTS: A total of 819 women were enrolled, of which 729 were suitable for analysis. Of these, 78 (10.7%) women developed PE (24 early onset and 54 late onset). Median sFlt-1/PlGF ratio at 20, 24 and 28 weeks was 6.3 (interquartile range (IQR), 4.1-9.3), 4.0 (IQR, 2.6-6.3) and 3.3 (IQR, 2.0-5.9), respectively, for women who did not develop PE (controls); 14.5 (IQR, 5.5-43.7), 18.4 (IQR, 8.2-57.9) and 51.9 (IQR, 11.5-145.6) for women with early-onset PE; and 6.7 (IQR, 4.6-9.9), 4.7 (IQR, 2.8-7.2) and 6.0 (IQR, 3.8-10.5) for women with late-onset PE. Compared with early-onset PE, the sFlt-1/PlGF ratio was significantly lower in controls (P < 0.001 at each timepoint) and in women with chronic hypertension (P < 0.001 at each timepoint), gestational hypertension (P < 0.001 at each timepoint) and late-onset PE (P < 0.001 at each timepoint). A prediction model for early-onset PE was developed, which included the sFlt-1/PlGF ratio plus mean arterial pressure, being parous and previous PE, with areas under the receiver-operating characteristics curves of 0.86 (95% CI, 0.77-0.95), 0.91 (95% CI, 0.85-0.97) and 0.93 (95% CI, 0.86-0.99) at 20, 24 and 28 weeks, respectively, and was superior to models using the sFlt-1/PlGF ratio alone or uterine artery mean pulsatility index. CONCLUSIONS: The sFlt-1/PlGF ratio can improve prediction of early-onset PE for women at risk of this condition. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
dc.language.iso eng
dc.publisher WILEY
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/ *
dc.subject.mesh Adult
dc.subject.mesh Biomarkers/blood
dc.subject.mesh Double-Blind Method
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Placenta Growth Factor/blood
dc.subject.mesh Pre-Eclampsia/blood/diagnosis/diagnostic imaging
dc.subject.mesh Predictive Value of Tests
dc.subject.mesh Pregnancy
dc.subject.mesh Pregnancy Outcome
dc.subject.mesh Pregnancy Trimester, Second
dc.subject.mesh Prenatal Diagnosis
dc.subject.mesh Prospective Studies
dc.subject.mesh Spain
dc.subject.mesh Ultrasonography, Prenatal
dc.subject.mesh Vascular Endothelial Growth Factor Receptor-1/blood
dc.title sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain)
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 27883242
dc.relation.publisherversion https://obgyn.onlinelibrary.wiley.com/doi/10.1002/uog.17373
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1002/uog.17373
dc.journal.title Ultrasound in Obstetrics & Gynecology
dc.identifier.essn 1469-0705


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta